European growth debt fund Claret Capital Partners raises €575M, with a third earmarked for biotech, medtech and diagnostics deals.
European firm Claret Capital Partners has raised €575 million in its latest round, dubbed Fund IV, and a sizable portion will be lent out to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Claret’s latest fundraise exceeded its €500 million target, increasing the scale of capital available for growth lending to…
Claret Capital Partners has closed its fourth growth debt fund at €575M, comprising €440M of Fund IV commitments and €135M of…
Paris and San Francisco-based Lauxera Capital Partners has closed a €520M healthtech growth fund to help commercial-stage…
Claris Bio has appointed veteran CEO Stephen Brady to lead advanced development of what it hopes to be the first drug therapy for…
The biggest issue Europe’s life sciences sector faces is fragmentation.
Climentum Capital Fund II is targeting €100 million to invest in around 20 early-stage climatetech companies developing…
Kapital raises $125M to push its AI banking platform into the US and Europe
